Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Green tea mouthwash is an herbal oral rinse formulated from the extract of *Camellia sinensis* leaves, containing bioactive polyphenols such as epigallocatechin-3-gallate (EGCG). In research conducted by Cairo University, it is evaluated for its efficacy in treating plaque-induced gingivitis, particularly in pediatric populations. The mouthwash functions through a multi-targeted mechanism: it exerts antimicrobial effects by inhibiting the growth and adhesion of dental plaque bacteria (e.g., *Streptococcus mutans*), and it provides anti-inflammatory benefits by reducing the expression of pro-inflammatory cytokines and inhibiting matrix metalloproteinases (MMPs) that contribute to tissue degradation. It is positioned as a natural, non-staining alternative to traditional chemical agents like chlorhexidine.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Green tea mouthwash.